1-Phenyl-N-(4-(trifluoromethoxy)phenyl)cyclopentane-1-carboxamide

Catalog No. :
ACXFLP442
CAS No. :
1024081-90-0
Molecular Formula :
C19H18F3NO2
Molecular Weight :
349.35

IUPAC Name:1-phenyl-N-(4-(trifluoromethoxy)phenyl)cyclopentane-1-carboxamide

1-Phenyl-N-(4-(trifluoromethoxy)phenyl)cyclopentane-1-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$121.00Login to see priceInquiryInquiry
10mg98%$148.00Login to see priceInquiryInquiry
50mg98%$209.00Login to see priceInquiryInquiry
100mg98%$276.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Phenyl-N-(4-(trifluoromethoxy)phenyl)cyclopentane-1-carboxamide
IUPAC Name1-phenyl-N-(4-(trifluoromethoxy)phenyl)cyclopentane-1-carboxamide
Molecular FormulaC19H18F3NO2
Molecular Weight349.35
SMILESO=C(C1(C2=CC=CC=C2)CCCC1)NC3=CC=C(OC(F)(F)F)C=C3
InChI KeyLHZBJDLQZNDILU-UHFFFAOYSA-N
Synonym(PHENYLCYCLOPENTYL)-N-(4-(TRIFLUOROMETHOXY)PHENYL)FORMAMIDE;1-phenyl-N-[4-(trifluoromethoxy)phenyl]cyclopentane-1-carboxamide;Cyclopentanecarboxamide, 1-phenyl-N-[4-(trifluoromethoxy)phenyl]-;1-Phenyl-N-[4-(trifluoromethoxy)phenyl]cyclopentanecarboxamide
CAS No.1024081-90-0

Synthetic Route by SureRoute

1. ACXFLP442 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRCMF463 route compound structure diagram
    ACRCMF46342823-24-5 In Stock
  2. Plus
  3. ACSELK752 route compound structure diagram
    ACSELK75277-55-4 In Stock
  4. Then
  5. ACXFLP442 route product structure diagram
    ACXFLP4421024081-90-0
Inquiry

2. ACXFLP442 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRCMF463 route compound structure diagram
    ACRCMF46342823-24-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXFLP442 route product structure diagram
    ACXFLP4421024081-90-0
Inquiry

Comments (0)